![Nicholas Grund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Grund
Corporate Officer/Principal chez
AKEBIA THERAPEUTICS, INC.
Fortune : 337 330 $ au 31/05/2026
Profil
Nicholas P.
Grund is Chief Commercial Officer & Senior Vice President at Akebia Therapeutics, Inc. since 2024.
Formerly, Mr. Grund was Head-Specialty Care at Genzyme Corp.
from 2007 to 2015, Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2016 to 2019, President-Eurofins at Transplant Genomics, Inc. from 2021 to 2022, and Principal at Bayer Diagnostics Corp.
from 1995 to 2002.
Mr. Grund earned an MBA from Northeastern University and completed undergraduate studies at the University of Massachusetts.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 330 716 ( 0,12 % ) | 337 330 $ | 31/05/2026 |
Postes actifs de Nicholas Grund
| Sociétés | Poste | Début |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | 09/01/2024 |
Anciens postes connus de Nicholas Grund
| Sociétés | Poste | Fin |
|---|---|---|
Transplant Genomics, Inc.
 Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Corporate Officer/Principal | 01/11/2022 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 29/03/2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/12/2015 |
Bayer Diagnostics Corp.
 Bayer Diagnostics Corp. Medical SpecialtiesHealth Technology Provides diagnostic and research services | Corporate Officer/Principal | 01/01/2002 |
Formation de Nicholas Grund
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Bayer Diagnostics Corp.
Bayer Diagnostics Corp. Medical SpecialtiesHealth Technology Provides diagnostic and research services | Health Technology |
Transplant Genomics, Inc.
Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
